Audrain-McGovern J - Search Results

1

Cigarette smoking practices among American college students: review and future directions.

Patterson F, Lerman C, Kaufmann VG, Neuner GA, Audrain-McGovern J. Patterson F, et al. J Am Coll Health. 2004 Mar-Apr;52(5):203-10. doi: 10.3200/JACH.52.5.203-212. J Am Coll Health. 2004. PMID: 15029942 Review.

2

Effecting behavior change: awareness of family history.

Audrain-McGovern J, Hughes C, Patterson F. Audrain-McGovern J, et al. Am J Prev Med. 2003 Feb;24(2):183-9. doi: 10.1016/s0749-3797(02)00592-5. Am J Prev Med. 2003. PMID: 12568825 Review.

3

Which adolescents are most receptive to tobacco industry marketing? implications for counter-advertising campaigns.

Audrain-McGovern J, Tercyak KP, Shields AE, Bush A, Espinel CF, Lerman C. Audrain-McGovern J, et al. Health Commun. 2003;15(4):499-513. doi: 10.1207/S15327027HC1504_07. Health Commun. 2003. PMID: 14527869

4

Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling.

Patterson F, Jepson C, Kaufmann V, Rukstalis M, Audrain-McGovern J, Kucharski S, Lerman C. Patterson F, et al. Drug Alcohol Depend. 2003 Nov 24;72(2):123-31. doi: 10.1016/s0376-8716(03)00194-7. Drug Alcohol Depend. 2003. PMID: 14636967 Clinical Trial.

5

Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome.

Kaufmann V, Jepson C, Rukstalis M, Perkins K, Audrain-McGovern J, Lerman C. Kaufmann V, et al. Psychopharmacology (Berl). 2004 Mar;172(3):271-6. doi: 10.1007/s00213-003-1659-8. Epub 2003 Nov 25. Psychopharmacology (Berl). 2004. PMID: 14647969 Clinical Trial.

6

Smoking progression and physical activity.

Audrain-McGovern J, Rodriguez D, Moss HB. Audrain-McGovern J, et al. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1121-9. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652270

7

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.

Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C. Collins BN, et al. Nicotine Tob Res. 2004 Feb;6(1):27-37. doi: 10.1080/14622200310001656830. Nicotine Tob Res. 2004. PMID: 14982685 Clinical Trial.

8

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.

Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH. Lerman C, et al. Pharmacogenomics J. 2004;4(3):184-92. doi: 10.1038/sj.tpj.6500238. Pharmacogenomics J. 2004. PMID: 15007373 Clinical Trial.

9

Ethical issues in conducting behavioral genetics research: the case of smoking prevention trials among adolescents.

Wilfond BS, Geller G, Lerman C, Audrain-McGovern J, Shields AE. Wilfond BS, et al. J Health Care Law Policy. 2002;6(1):73-88. J Health Care Law Policy. 2002. PMID: 15017952 No abstract available.

10

Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.

Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N. Lerman C, et al. Ann Intern Med. 2004 Mar 16;140(6):426-33. doi: 10.7326/0003-4819-140-6-200403160-00009. Ann Intern Med. 2004. PMID: 15023708 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters